LianBio to Participate in the Bank of America Securities 2022 Healthcare Conference

Rhea-AI Summary

LianBio (Nasdaq: LIAN), a biotechnology company focused on innovative medicines for patients in China and Asia, will participate in the Bank of America Securities 2022 Healthcare Conference from May 10-13, 2022, in Las Vegas. A key event includes a fireside chat on May 12, 2022, at 9:20 a.m. A live audio webcast of this chat will be available on LianBio's investors webpage, with a replay accessible post-event. LianBio aims to enhance healthcare standards across various medical fields through global partnerships, targeting underserved patients in their markets.

SHANGHAI, China and PRINCETON, N.J., May 05, 2022 (GLOBE NEWSWIRE) --  LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced that management will participate in the Bank of America Securities 2022 Healthcare Conference being held in person in Las Vegas on May 10-13, 2022. Management is scheduled to participate in a fireside chat on May 12, 2022 at 9:20 a.m.

A live audio webcast of the fireside chat will be accessible from the Investors section of LianBio’s website at https://investors.lianbio.com/ with a replay available following the live event.

About LianBio

LianBio is a cross-border biotechnology company on a mission to bring transformative medicines to historically underserved patients in China and other Asian markets. Through partnerships with highly innovative biopharmaceutical companies around the world, LianBio is advancing a diversified portfolio of clinically validated product candidates with the potential to drive new standards of care across cardiovascular, oncology, ophthalmology, inflammatory disease and respiratory indications. LianBio is establishing an international infrastructure to position the company as a partner of choice with a platform to provide access to China and other Asian markets. For more information, please visit www.lianbio.com.

For investor inquiries, please contact:

Elizabeth Anderson, VP Communications and Investor Relations

E: elizabeth.anderson@lianbio.com

T: +1 646 655 8390

For media inquiries, please contact:

Katherine Smith, CanaleComm

E: katherine.smith@canalecomm.com

T: +1 619 849 5378

FAQ

When will LianBio participate in the Bank of America Securities 2022 Healthcare Conference?

LianBio will participate in the Bank of America Securities 2022 Healthcare Conference from May 10-13, 2022.

What time is LianBio's fireside chat at the Healthcare Conference?

LianBio's fireside chat is scheduled for May 12, 2022, at 9:20 a.m.

Where can I watch the live audio webcast of LianBio's fireside chat?

The live audio webcast will be available on LianBio's investors section of their website.

What is LianBio's mission?

LianBio's mission is to bring transformative medicines to underserved patients in China and other Asian markets.

What therapeutic areas does LianBio focus on?

LianBio focuses on cardiovascular, oncology, ophthalmology, inflammatory disease, and respiratory indications.